QJBIOCH(SH:600796)2024-04-25 08:33Revenue and Profit - Revenue for Q1 2024 was CNY 373,985,726.46, an increase of 4.52% compared to the same period last year[5] - Net profit attributable to shareholders decreased by 5.15% to CNY 28,777,812.43[5] - Net profit excluding non-recurring gains and losses increased by 13.34% to CNY 27,135,623.27[5] - Total operating revenue for Q1 2024 was CNY 373,985,726.46, an increase of 4.3% compared to CNY 357,819,300.48 in Q1 2023[21] - Operating income for Q1 2024 was CNY 16,767,422.20, compared to CNY 15,159,094.82 in Q1 2023, indicating a growth of 10.6%[21] - Net profit for Q1 2024 was CNY 20,691,710.04, down from CNY 25,115,818.28 in Q1 2023, representing a decline of about 17.5%[23] - The total profit for Q1 2024 was CNY 29,801,675.53, down from CNY 34,425,573.09 in Q1 2023, a decrease of approximately 13.5%[22] Cash Flow and Assets - Operating cash flow showed a significant decline, with a net outflow of CNY 95,803,216.03, a decrease of 1,012.82%[5][10] - Cash and cash equivalents as of March 31, 2024, were CNY 515,952,827.88, down from CNY 876,278,033.34 as of December 31, 2023, representing a decrease of 41.1%[16] - Cash flow from operating activities for Q1 2024 was negative at CNY -95,803,216.03, compared to CNY -8,609,087.18 in Q1 2023, indicating a worsening cash flow situation[27] - The company reported a net cash outflow from investing activities of CNY -234,566,513.83 in Q1 2024, compared to CNY -17,309,858.90 in Q1 2023, indicating increased investment expenditures[27] Shareholder Equity and Assets - Total assets at the end of the reporting period were CNY 6,658,869,622.35, down 3.09% from the end of the previous year[6] - Shareholder equity increased slightly by 0.93% to CNY 3,167,420,384.15[6] - Total assets as of March 31, 2024, were CNY 6,658,869,622.35, down from CNY 6,871,323,089.13 at the end of 2023, a decrease of 3.1%[19] - Total liabilities decreased to CNY 3,140,933,330.56 from CNY 3,374,593,671.20, a reduction of 6.9%[19] - Shareholders' equity increased to CNY 3,517,936,291.79 from CNY 3,496,729,417.93, an increase of 0.6%[19] Costs and Expenses - Total operating costs for Q1 2024 were CNY 357,218,304.26, up from CNY 342,660,205.66 in Q1 2023, reflecting a year-over-year increase of 4.5%[21] - R&D expenses for Q1 2024 were CNY 5,008,497.68, a decrease from CNY 6,814,606.71 in Q1 2023, reflecting a reduction of approximately 26.5%[22] - The company experienced a significant increase in financial expenses, totaling CNY 17,504,579.86 in Q1 2024, compared to CNY 20,840,711.43 in Q1 2023, a decrease of about 16.4%[22] Inventory and Receivables - Accounts receivable decreased to CNY 721,506,027.59 from CNY 873,093,421.87, a decline of 17.4%[17] - Inventory increased to CNY 203,050,056.40 from CNY 195,914,725.60, reflecting a rise of 3.5%[17] - Long-term investments rose to CNY 484,157,241.82 from CNY 474,560,340.45, an increase of 2.0%[17] Earnings Per Share - Basic earnings per share decreased by 25.00% to CNY 0.03[6] - The basic and diluted earnings per share for Q1 2024 were both CNY 0.03, down from CNY 0.04 in Q1 2023, reflecting a decrease of 25%[23]